Biotech Values

[henrym28]

I haven't seen a chart this ugly in a long long time. This stock literally never goes up. Management is not being upfront and the market sniffed it out a while ago. The secondary at $17 was a red flag. The delayed BLA filing due to this sudden need to include 100U is the icing on the cake. This company will be forced to raise again in the single digits prelaunch. And there you have it..textbook shareholder destruction.

The only thing that can save this abomination is a partnership or straight acquisition. But Daniel will surely find a way to screw the equity holders in either of those two scenarios.